SG10201605314TA - Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation - Google Patents

Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation

Info

Publication number
SG10201605314TA
SG10201605314TA SG10201605314TA SG10201605314TA SG10201605314TA SG 10201605314T A SG10201605314T A SG 10201605314TA SG 10201605314T A SG10201605314T A SG 10201605314TA SG 10201605314T A SG10201605314T A SG 10201605314TA SG 10201605314T A SG10201605314T A SG 10201605314TA
Authority
SG
Singapore
Prior art keywords
premature ejaculation
treating premature
pharmaceutical composition
treating
ejaculation
Prior art date
Application number
SG10201605314TA
Other languages
English (en)
Inventor
Hong-Ryeol Jeon
Do-Woo Kwon
Bong-Sang Lee
Seong-Shin Kwak
Sun-Ahe Lee
Hyun-Jung Park
Jeong-Hwa Yoo
Original Assignee
Ctc Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ctc Bio Inc filed Critical Ctc Bio Inc
Publication of SG10201605314TA publication Critical patent/SG10201605314TA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG10201605314TA 2011-06-28 2012-06-28 Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation SG10201605314TA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20110062620 2011-06-28

Publications (1)

Publication Number Publication Date
SG10201605314TA true SG10201605314TA (en) 2016-08-30

Family

ID=47424682

Family Applications (1)

Application Number Title Priority Date Filing Date
SG10201605314TA SG10201605314TA (en) 2011-06-28 2012-06-28 Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation

Country Status (20)

Country Link
US (2) US20140200210A1 (de)
EP (2) EP2727595B1 (de)
JP (1) JP6042886B2 (de)
KR (1) KR101978459B1 (de)
CN (1) CN103635194B (de)
AU (1) AU2012276476B2 (de)
BR (1) BR112013033475A2 (de)
CA (1) CA2840521C (de)
EA (1) EA029932B1 (de)
ES (1) ES2668943T3 (de)
HK (1) HK1193050A1 (de)
IL (1) IL230174A (de)
MA (1) MA35610B1 (de)
MX (1) MX367663B (de)
MY (1) MY167609A (de)
SG (1) SG10201605314TA (de)
TN (1) TN2013000526A1 (de)
UA (1) UA112652C2 (de)
WO (1) WO2013002578A2 (de)
ZA (1) ZA201400653B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150079449A (ko) 2013-12-31 2015-07-08 주식회사 씨티씨바이오 클로미프라민 함유 약학 조성물 및 이의 제조 방법
EP3646871A1 (de) * 2018-10-30 2020-05-06 SEROJAC PME Handels GmbH Behandlung und prävention von vorzeitiger ejakulation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403597B1 (en) * 1997-10-28 2002-06-11 Vivus, Inc. Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
US6495154B1 (en) * 2000-11-21 2002-12-17 Vivus Inc. On demand administration of clomipramine and salts thereof to treat premature ejaculation
US20030229001A1 (en) * 2002-01-31 2003-12-11 Pfizer Inc. Treatment of male sexual dysfunction
EP1663180A1 (de) * 2003-09-15 2006-06-07 Vectura Limited Pharmazeutische zusammensetzungen zur behandlung von vorzeitiger ejakulation durch pulmonale inhalation
WO2007000764A2 (en) * 2005-06-27 2007-01-04 Daniel Drai Compositions and methods for enhancement of sexual function
US20070166344A1 (en) 2006-01-18 2007-07-19 Xin Qu Non-leaching surface-active film compositions for microbial adhesion prevention
JP4584339B2 (ja) 2008-02-20 2010-11-17 ダイワボウホールディングス株式会社 抗ウイルス物質、抗ウイルス繊維及び抗ウイルス繊維構造物
CN102036669B (zh) * 2008-05-19 2013-05-15 株式会社柳韩洋行 用于治疗早泄的药物组合物
KR20110062620A (ko) 2009-12-03 2011-06-10 유비벨록스(주) 전자지갑디바이스를 이용한 금융 제휴서비스 제공시스템 및 이를 이용한 금융 제휴서비스제공방법

Also Published As

Publication number Publication date
BR112013033475A2 (pt) 2017-12-19
EP3323416B1 (de) 2020-04-22
WO2013002578A2 (ko) 2013-01-03
CA2840521A1 (en) 2013-01-03
AU2012276476A1 (en) 2014-02-13
EP2727595A4 (de) 2015-03-04
IL230174A (en) 2017-07-31
UA112652C2 (uk) 2016-10-10
KR20140043898A (ko) 2014-04-11
CN103635194A (zh) 2014-03-12
US20140200210A1 (en) 2014-07-17
HK1193050A1 (zh) 2014-09-12
JP2014527513A (ja) 2014-10-16
MA35610B1 (fr) 2014-11-01
EP3323416A1 (de) 2018-05-23
EA029932B1 (ru) 2018-05-31
EP2727595A2 (de) 2014-05-07
TN2013000526A1 (en) 2015-03-30
CA2840521C (en) 2019-11-26
EA201490173A1 (ru) 2014-04-30
AU2012276476B2 (en) 2017-06-29
MX367663B (es) 2019-08-30
CN103635194B (zh) 2016-02-10
JP6042886B2 (ja) 2016-12-14
MY167609A (en) 2018-09-20
US20190224208A1 (en) 2019-07-25
ZA201400653B (en) 2016-11-30
ES2668943T3 (es) 2018-05-23
KR101978459B1 (ko) 2019-05-14
MX2014000082A (es) 2014-05-01
EP2727595B1 (de) 2018-02-21
WO2013002578A3 (ko) 2013-04-11

Similar Documents

Publication Publication Date Title
HK1201475A1 (en) Methods and compositions for treating pain
EP2684167A4 (de) Zusammensetzungen und verfahren zur behandlung von erkrankungen
PL2672966T3 (pl) Kompozycja farmaceutyczna, sposoby leczenia i jej zastosowania
ZA201305783B (en) Composition and methods for treating cardiovascular diseases
HK1190610A1 (zh) 種改善疲勞的藥物組合物及其製備方法
HUE054621T2 (hu) Gyógyászáti készítmény, kezelési eljárások és alkalmazásaik
EP2890391A4 (de) Verfahren und zusammensetzung zur behandlung von hyperglykämie
EP2655334A4 (de) Zusammensetzungen und verfahren zur behandlung von erkrankungen
EP2701742A4 (de) Zusammensetzungen und verfahren zur behandlung von autoimmunerkrankungen
EP2771030A4 (de) Zusammensetzungen und verfahren zur behandlung von proteinopathien
GB201408236D0 (en) Composition and method
GB201122195D0 (en) Composition and method
EP2666469A4 (de) Pharmazeutische zusammensetzung zur behandlung von melasma und herstellungsverfahren dafür
EP2766009A4 (de) Verfahren und zusammensetzungen zur hautbehandlung
EP2736437A4 (de) Verfahren und zusammensetzung zur hyperthermalen behandlung von zellen
EP2709614A4 (de) Pharmazeutische zusammensetzung und verfahren zur behandlung von krebs
ZA201303222B (en) Composition and method for treating skin conditions
HK1259004A1 (zh) 治療糖尿病的組合物和方法
IL231505A0 (en) Pharmaceutical preparation and method for its production
HK1243637A1 (zh) 順勢療法的治療方法及其組合物
SG11201400976WA (en) Methods and pharmaceutical compositions for treating cancer
HK1188566A1 (zh) 治療癌症的組合物和方法
EP2566478A4 (de) Pharmazeutische zusammensetzung und verfahren zur behandlung von bluthochdruck
HK1193050A1 (zh) 用於治療早泄的藥物組合物以及用於治療早泄的方法
GB201106433D0 (en) Composition and method